FDA Authorizes Updated Novavax COVID-19 Vaccine to Better Protect Against Currently Circulating Variants

Estimated reading time: 1 minutes

• About The Author

FDA authorized for emergency use Novavax COVID-19 Vaccine (2024-2025 Formula) to more closely target currently circulating variants to provide better protection against serious consequences of COVID-19.

About The Author

See author's posts

Trending

Google Ranking Factors and Marketing KPIs